"PROGRESS is our most important product": Adventures in CTO intervention

Nachiket J Patel^{1

2}, Richard R Heuser^{1

3}

Affiliations

Editorial

Nachiket J Patel et al. Catheter Cardiovasc Interv. 2021 Mar.

. 2021 Mar;97(4):668-669.

doi: 10.1002/ccd.29570.

Nachiket J Patel^{1

2}, Richard R Heuser^{1

3}

No abstract available

Comment on

Equipment utilization in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.
Nikolakopoulos I, Choi JW, Alaswad K, Khatri JJ, Krestyaninov O, Khelimskii D, Yeh RW, Jaffer FA, Toma C, Patel M, Mahmud E, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Gkargkoulas F, Uretsky B, Sheikh AM, Vemmou E, Xenogiannis I, Rangan BV, Garcia S, Abdullah S, Banerjee S, Burke MN, Brilakis ES, Karmpaliotis D. Nikolakopoulos I, et al. Catheter Cardiovasc Interv. 2021 Mar;97(4):658-667. doi: 10.1002/ccd.29106. Epub 2020 Jun 29. Catheter Cardiovasc Interv. 2021. PMID: 32597031

1. Nikolakopoulos I, Choi JW, Alaswad K, et al. Equipment utilization in chronic total occlusion percutaneous coronary interventions: insights from the PROGRESS-CTO registry. Catheter Cardiovasc Interv. 2021;97:658-667.